RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. European Equity Partners
E

European Equity Partners portfolio

European Equity Partners has 1 portfolio company on record at Recent Funding.

Website: eeplp.com.
Type: Growth equity.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $32.83M.
Latest deal: Bactolife · Aug 8, 2023.
About this page

It is a growth equity firm based in Saint Peter Port, GG, founded in 1999. Its most recent investment on record is Bactolife's $32.83M Series A round in August 2023, alongside Novo Holdings, Bill & Melinda Gates Foundation and Athos Capital. That company is in Health and bio.

About European Equity Partners

Firm type: Growth equity.
Headquarters: Saint Peter Port, GG.
Founded: 1999.
Stages: Seed, Series A, Growth.
Sectors: Biotech, Deep Tech, Healthtech, Media & Entertainment, Medical Devices.
Check size: $540K to $10.8M.
Leads rounds: Yes.
Portfolio companies: 17.
Exits: 4.
Rounds led: 0.

What European Equity Partners invests in

How European Equity Partners invests

StageDealsCapital in rounds
Series A 1 100%$32.83M

European Equity Partners portfolio companies

CompanyRound with European Equity PartnersTotal raisedLatest raise
BBactolife
Health and bio
Series A · $32.83M$76.16MJan 6, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name European Equity Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists European Equity Partners, which is a subset of its real portfolio. API: /api/v1/investors/european-equity-partners (get a free API key). More: the most active VC firms and new venture capital funds.